Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 14;20(10):18620-60.
doi: 10.3390/molecules201018620.

A Systematic Review of the Anxiolytic-Like Effects of Essential Oils in Animal Models

Affiliations
Review

A Systematic Review of the Anxiolytic-Like Effects of Essential Oils in Animal Models

Damião Pergentino de Sousa et al. Molecules. .

Abstract

The clinical efficacy of standardized essential oils (such as Lavender officinalis), in treating anxiety disorders strongly suggests that these natural products are an important candidate source for new anxiolytic drugs. A systematic review of essential oils, their bioactive constituents, and anxiolytic-like activity is conducted. The essential oil with the best profile is Lavendula angustifolia, which has already been tested in controlled clinical trials with positive results. Citrus aurantium using different routes of administration also showed significant effects in several animal models, and was corroborated by different research groups. Other promising essential oils are Citrus sinensis and bergamot oil, which showed certain clinical anxiolytic actions; along with Achillea wilhemsii, Alpinia zerumbet, Citrus aurantium, and Spiranthera odoratissima, which, like Lavendula angustifolia, appear to exert anxiolytic-like effects without GABA/benzodiazepine activity, thus differing in their mechanisms of action from the benzodiazepines. The anxiolytic activity of 25 compounds commonly found in essential oils is also discussed.

Keywords: anxiety; anxiolytic; elevated plus maze; essential oil; lavender; natural products; relaxant; sedative; terpene; tranquillizer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

Cited by

References

    1. Nash J.R., Nutt D.J. Pharmacotherapy of anxiety. Handb. Exp. Pharmacol. 2005;169:469–501. - PubMed
    1. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., van Rompay M., Kessler R.C. Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. JAMA. 1998;280:1569–1575. doi: 10.1001/jama.280.18.1569. - DOI - PubMed
    1. Andreatini R., Faustino T.T., Almeida R.B. Medicinal plants for the treatment of generalized anxiety disorder: A review of controlled clinical studies. Rev. Bras. Psiquiatr. 2010;32:429–436. - PubMed
    1. Kasper S., Gastpar M., Müller W.E., Volz H.P., Möller H.J., Dienel A., Schläfke S. Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder—Evidence from clinical trials. Wien Med. Wochenschr. 2010;160:547–556. doi: 10.1007/s10354-010-0845-7. - DOI - PubMed
    1. Griebel G., Holmes A. 50 years of hurdles and hope in anxiolytic drug discovery. Nat. Rev. Drug Discov. 2013;12:667–687. doi: 10.1038/nrd4075. - DOI - PMC - PubMed

MeSH terms